Clinical Trials Browser

Phase 1/2 × Adenocarcinoma of Lung × Biopsy, Needle × Clear all

NCT01259089 2019-09-11

Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Phase 1/2 Completed

38 enrolled 12 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung